| PET imaging of blood flow and glucose metabolism in localized musculoskeletal tumors of the extremities. | |
| | |
MedLine Citation:
|
PMID: 21315286 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
INTRODUCTION: Little is known about blood flow in sarcomas. Our purpose was to study glucose metabolism and blood flow in untreated localized musculoskeletal tumors of the extremities using [(18)F]fluorodeoxyglucose (FDG), oxygen-15 labeled water ([15O]H(2)O) and positron emission tomography (PET). METHODS: Six patients with high-grade osteosarcoma (OS), two with soft-tissue sarcoma (STS) and one with aneurysmal bone cyst had PET studies with [15O]H(2)O and FDG. Arterial blood sampling and autoradiography calculation method were used to define blood flow as milliliters per 100 g times minutes. Tumor FDG uptake was measured as standardized uptake values (SUVs) and regional metabolic rates for FDG (rMRFDG). Two patients also had FDG PET studies during (one patient) and after (two patients) preoperative chemotherapy. All patients underwent dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI). The PET findings were compared with the clinical follow-up data and results of DCE-MRI. RESULTS: Blood flow in bone tumors was 31.7-75.2 ml/(100 g×min) and in STS 9.0-45.9 ml/(100 g×min). [(18)F]-Fluorodeoxyglucose uptake and rMRFDG in untreated bone tumors were 5.4-18.4 and 10.9-57.4 μmol/100 g/min, respectively. [(18)F]-Fluorodeoxyglucose uptake and rMRFDG in STS were 2.6-11.5 and 5.6-32.2 μmol/100 g/min, respectively. Four of five sarcomas with SUV>9.0 have already relapsed. High blood flow in untreated OS was related to long overall survival, while the predictive power of glucose metabolism was less apparent. Good histopathological response to therapy was not associated with long survival. CONCLUSIONS: Measurement of blood flow in musculoskeletal tumors appears to be feasible by PET and [(15)O]H(2)O. The influence of tumor blood flow and glucose metabolism on the final outcome in sarcoma is variable and needs further research. |
| | |
Authors:
|
Paula Lindholm; Eija Sutinen; Vesa Oikonen; Kimmo Mattila; Maija Tarkkanen; Markku Kallajoki; Hannu Aro; Tom Böhling; Aarne Kivioja; Inkeri Elomaa; Heikki Minn |
Related Documents
:
|
8249626 - Effects of tetrandrine on production of leukotriene b4 and thromboxane b2 in rabbit blood. 16303236 - Overland flow model for asphalt oil spills. 20619006 - Assessing the human immune system through blood transcriptomics. 19932056 - The first results demonstrating efficiency and safety of a double-column whole blood me... 1502266 - In vitro and in vivo ultraviolet-induced alterations of oxy- and deoxyhemoglobin. 7353336 - Effects of disease and acetazolamide on procaine hydrolysis by red blood cell enzymes. |
Publication Detail:
|
Type: Journal Article Date: 2010-10-27 |
Journal Detail:
|
Title: Nuclear medicine and biology Volume: 38 ISSN: 1872-9614 ISO Abbreviation: Nucl. Med. Biol. Publication Date: 2011 Feb |
Date Detail:
|
Created Date: 2011-02-14 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9304420 Medline TA: Nucl Med Biol Country: England |
Other Details:
|
Languages: eng Pagination: 295-300 Citation Subset: IM |
Copyright Information:
|
Copyright © 2011 Elsevier Inc. All rights reserved. |
Affiliation:
|
Department of Oncology and Radiotherapy, Turku University Hospital, Turku FI-20521, Finland; Turku PET Centre, Turku, Finland. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Reduction of stimulated sodium iodide symporter expression by estrogen receptor ligands in breast ca...
Next Document: A study of 90-day outcomes for a cohort of patients admitted to an Australian metropolitan acute str...